Literature DB >> 10332934

Realistic expectations for the management of Alzheimer's disease.

H Brodaty1.   

Abstract

Alzheimer's disease (AD) is a chronic and progressive neurodegenerative disorder characterized clinically by cognitive and functional deficits and behavioural disturbances. Over the past two decades, the devastating nature of AD has captured the attention of the general and medical communities alike. This is due partly to the increased prevalence of AD and the expansion of the aged population. Furthermore, and perhaps inappropriately, the media have encouraged speculation concerning a 'cure' for AD. Such treatment strategies are in the early stages of pre-clinical investigation and well-designed clinical trials are awaited. Nevertheless, other strategies, aimed at reducing the progression or effects through pharmacological symptomatic therapies and psychosocial interventions have demonstrated some clinical benefit and are now available and practicable. This paper critically evaluates the merits of both currently available and potential future therapeutic strategies according to primary, secondary and tertiary levels of preventative treatment.

Entities:  

Mesh:

Year:  1999        PMID: 10332934     DOI: 10.1016/s0924-977x(98)00044-3

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  5 in total

1.  Protective Effects of Donepezil Against Alcohol-Induced Toxicity in Cell Culture: Role of Caspase-3.

Authors:  Bruk Getachew; Tamaro Hudson; Thomas Heinbockel; Antonei B Csoka; Yousef Tizabi
Journal:  Neurotox Res       Date:  2018-05-26       Impact factor: 3.911

Review 2.  Donepezil: a review of its use in Alzheimer's disease.

Authors:  M Dooley; H M Lamb
Journal:  Drugs Aging       Date:  2000-03       Impact factor: 3.923

Review 3.  Galantamine: a review of its use in Alzheimer's disease.

Authors:  L J Scott; K L Goa
Journal:  Drugs       Date:  2000-11       Impact factor: 9.546

4.  Synthesis of Novel 3-Aryl-N-Methyl-1,2,5,6-Tetrahydropyridine Derivatives by Suzuki coupling: As Acetyl Cholinesterase Inhibitors.

Authors:  S B Benaka Prasad; Y C Sunil Kumar; C S Ananda Kumar; C T Sadashiva; K Vinaya; K S Rangappa
Journal:  Open Med Chem J       Date:  2007-09-05

5.  Transdermal donepezil on the treatment of Alzheimer's disease.

Authors:  Piera Sozio; Laura S Cerasa; Lisa Marinelli; Antonio Di Stefano
Journal:  Neuropsychiatr Dis Treat       Date:  2012-08-20       Impact factor: 2.570

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.